update

endpoint named preferred provider for Ferring Pharmaceuticals

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/shironosov)
(Image: iStock/shironosov)

Related tags: Management

Ferring Pharmaceuticals has selected endpoint as its sole leading interactive response technology (IRT) provider.

The preferred partnership extends a previously established relationship, which began in early 2015.

In a press statement, Chuck Harris, endpoint’s CEO described the preferred partnership as “a prime example of endpoint’s expansion across the global clinical trials industry.​”

"As a company who is exclusively focused on IRT, we are in a unique position to dedicate 100% of our resources and efforts to advancing our IRT solutions, thereby advancing the industry itself​," Harris told us.

According to the company, endpoint continues to grow in Europe through its full-service IRT solution, PULSE, and its enterprise supply management hub, DRIVE.

"Over the last year, we have made substantial progress in expanding our operations footprint across the globe, enabling endpoint to be better positioned geographically within several markets outside of the US, and by pushing the boundaries of ‘what is IRT’ through the expansion of its offerings​," Ryan Keane, Executive Director, Business Development, told Outsourcing-Pharma.com.

The clinical supply management tool, DRIVE, was introduced last year​ at DIA 2016 in June. The offering enables IRT functionality for non-IRT and investigator-sponsored trials.

The tool allows users to manage all elements of non-IRT and endpoint IRT studies electronically within a single system, with the ability to see supply at depots through a single view. 

Related news

Show more

Related products

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Global Clinical Trial Lab Services

Global Clinical Trial Lab Services

Q2 Solutions | 01-Apr-2020 | Product Presentation

As a leading global lab services partner, we provide operational excellence, scientific leadership and innovation through technology. We offer end-to-end...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us

Products

View more

Webinars